First use of CRISPR against cancer in patients clears early safety hurdles
ADOBE
In a small, early trial, doctors were able to take immune system cells from the patients' blood and alter them to help them recognize and fight cancer.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario